199 related articles for article (PubMed ID: 31280456)
1. Patterns of comorbidities in women with breast cancer: a Canadian population-based study.
Ng HS; Vitry A; Koczwara B; Roder D; McBride ML
Cancer Causes Control; 2019 Sep; 30(9):931-941. PubMed ID: 31280456
[TBL] [Abstract][Full Text] [Related]
2. Comorbidities in Australian women with hormone-dependent breast cancer: a population-based analysis.
Ng HS; Koczwara B; Roder DM; Niyonsenga T; Vitry AI
Med J Aust; 2018 Jan; 208(1):24-28. PubMed ID: 29320669
[TBL] [Abstract][Full Text] [Related]
3. Development of comorbidities in men with prostate cancer treated with androgen deprivation therapy: an Australian population-based cohort study.
Ng HS; Koczwara B; Roder D; Vitry A
Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):403-410. PubMed ID: 29720722
[TBL] [Abstract][Full Text] [Related]
4. Hyperthyroidism, Hypothyroidism, and Cause-Specific Mortality in a Large Cohort of Women.
Journy NMY; Bernier MO; Doody MM; Alexander BH; Linet MS; Kitahara CM
Thyroid; 2017 Aug; 27(8):1001-1010. PubMed ID: 28578598
[TBL] [Abstract][Full Text] [Related]
5. Primary care physician use across the breast cancer care continuum: CanIMPACT study using Canadian administrative data.
Jiang L; Lofters A; Moineddin R; Decker K; Groome P; Kendell C; Krzyzanowska M; Li D; McBride ML; Mittmann N; Porter G; Turner D; Urquhart R; Winget M; Zhang Y; Grunfeld E
Can Fam Physician; 2016 Oct; 62(10):e589-e598. PubMed ID: 27737994
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
[TBL] [Abstract][Full Text] [Related]
7. Developing a comorbidity index for comparing cancer outcomes in Aboriginal and non-Aboriginal Australians.
Pule L; Buckley E; Niyonsenga T; Banham D; Roder D
BMC Health Serv Res; 2018 Oct; 18(1):776. PubMed ID: 30326898
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Diabetes on Breast Cancer Treatments and Outcomes: A Population-Based Study.
Lega IC; Austin PC; Fischer HD; Fung K; Krzyzanowska MK; Amir E; Lipscombe LL
Diabetes Care; 2018 Apr; 41(4):755-761. PubMed ID: 29351960
[TBL] [Abstract][Full Text] [Related]
9. Endocrine Comorbidities in Patients with Psoriatic Arthritis: A Population-based Case-controlled Study.
Haddad A; Ashkenazi RI; Bitterman H; Feldhamer I; Greenberg-Dotan S; Lavi I; Batat E; Bergman I; Cohen AD; Zisman D
J Rheumatol; 2017 Jun; 44(6):786-790. PubMed ID: 28412706
[TBL] [Abstract][Full Text] [Related]
10. Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis.
Zhang T; Tremlett H; Leung S; Zhu F; Kingwell E; Fisk JD; Bhan V; Campbell TL; Stadnyk K; Yu BN; Marrie RA;
Neurology; 2016 Apr; 86(14):1287-1295. PubMed ID: 26944268
[TBL] [Abstract][Full Text] [Related]
11. Impact of Baseline Cardiovascular Comorbidity on Outcomes in Women With Breast Cancer: A Real-world, Population-based Study.
Abdel-Rahman O; Xu Y; Kong S; Dort J; Quan ML; Karim S; Bouchard-Fortier A; Cho H; Cheung WY
Clin Breast Cancer; 2019 Apr; 19(2):e297-e305. PubMed ID: 30630679
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease in women with breast cancer - a nationwide cohort study.
Jakobsen M; Kolodziejczyk C; Jensen MS; Poulsen PB; Khan H; Kümler T; Andersson M
BMC Cancer; 2021 Sep; 21(1):1040. PubMed ID: 34537007
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk of developing comorbid conditions in patients with chronic constipation.
Mody R; Guérin A; Fok B; Lasch KL; Zhou Z; Wu EQ; Zhou W; Talley NJ
Curr Med Res Opin; 2014 Dec; 30(12):2505-13. PubMed ID: 25215427
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of comorbidities in COPD patients by disease severity in a German population.
Greulich T; Weist BJD; Koczulla AR; Janciauskiene S; Klemmer A; Lux W; Alter P; Vogelmeier CF
Respir Med; 2017 Nov; 132():132-138. PubMed ID: 29229085
[TBL] [Abstract][Full Text] [Related]
15. Influence of specific comorbidities on survival after early-stage breast cancer.
Ewertz M; Land LH; Dalton SO; Cronin-Fenton D; Jensen MB
Acta Oncol; 2018 Jan; 57(1):129-134. PubMed ID: 29202645
[TBL] [Abstract][Full Text] [Related]
16. A cohort study of comorbidity in patients with granulomatosis with polyangiitis.
Li L; Neogi T; Jick S
Rheumatology (Oxford); 2018 Feb; 57(2):291-299. PubMed ID: 29069513
[TBL] [Abstract][Full Text] [Related]
17. Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study.
Jordan JH; Thwin SS; Lash TL; Buist DS; Field TS; Haque R; Pawloski PA; Petersen HV; Prout MN; Quinn VP; Yood MU; Silliman RA; Geiger AM
Breast Cancer Res Treat; 2014 Jul; 146(2):401-9. PubMed ID: 24939060
[TBL] [Abstract][Full Text] [Related]
18. Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study.
Laforest L; Roche N; Devouassoux G; Belhassen M; Chouaid C; Ginoux M; Van Ganse E
Respir Med; 2016 Aug; 117():33-9. PubMed ID: 27492511
[TBL] [Abstract][Full Text] [Related]
19. Low-Dose Aspirin Reduces Breast Cancer Risk in Women with Diabetes: A Nationwide Retrospective Cohort Study in Taiwan.
Yang YS; Kornelius E; Chiou JY; Lai YR; Lo SC; Peng CH; Huang CN
J Womens Health (Larchmt); 2017 Dec; 26(12):1278-1284. PubMed ID: 28537451
[TBL] [Abstract][Full Text] [Related]
20. Diabetes and differences in detection of incident invasive breast cancer.
Calip GS; Yu O; Boudreau DM; Shao H; Oratz R; Richardson SB; Gold HT
Cancer Causes Control; 2019 May; 30(5):435-441. PubMed ID: 30949885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
